NCT01639911 2019-07-22Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsUniversity of Illinois at ChicagoPhase 1 Completed28 enrolled
NCT01091428 2018-06-04Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerTakedaPhase 2 Completed191 enrolled 39 charts
NCT01045421 2016-08-15Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal MalignanciesMillennium Pharmaceuticals, Inc.Phase 1/2 Completed273 enrolled 28 charts